College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong 030801, China.
Beijing Solarbio Science & Technology Co., Ltd., Beijing 101102, China.
Viruses. 2023 May 25;15(6):1237. doi: 10.3390/v15061237.
Pseudorabies virus (PRV) variants have caused substantial economic losses in the swine industry in China since 2011. To surveil the genetic variation in PRV field strains, here, two novel variant strains of PRV were isolated from Shanxi Province in central China and were designated SX1910 and SX1911. To identify the genetic characteristics of the two isolates, their complete genomes were sequenced, and phylogenetic analysis and sequence alignment revealed that field PRV variants have undergone genetic variations; notably, the protein-coding sequences UL5, UL36, US1 and IE180 exhibited extensive variation and contained one or more hypervariable regions. Furthermore, we also found that the glycoproteins gB and gD of the two isolates had some novel amino acid (aa) mutations. Importantly, most of these mutations were located on the surface of the protein molecule, according to protein structure model analysis. We constructed a mutant virus of SX1911 with deletion of the gE and gI genes via CRISPR/Cas9. When tested in mice, SX1911-ΔgE/gI-vaccinated mice were protected within a comparable range to Bartha-K61-vaccinated mice. Additionally, a higher dose of inactivated Bartha-K61 protected the mice from lethal SX1911 challenge, while a lower neutralization titer, higher viral load and more severe microscopic lesions were displayed in Bartha-K61-vaccinated mice. These findings highlight the need for continuous monitoring of PRV and novel vaccine development or vaccination program design for PRV control in China.
自 2011 年以来,伪狂犬病毒(PRV)变异株在中国的养猪业中造成了巨大的经济损失。为了监测 PRV 田间毒株的遗传变异,本研究从中国中部山西省分离到了两株新型 PRV 变异株,分别命名为 SX1910 和 SX1911。为了鉴定这两株分离株的遗传特征,我们对其全基因组进行了测序,并进行了系统进化分析和序列比对,结果表明田间 PRV 变异株发生了遗传变异;特别是,UL5、UL36、US1 和 IE180 等蛋白编码序列发生了广泛的变异,并且包含一个或多个高变区。此外,我们还发现这两株分离株的糖蛋白 gB 和 gD 具有一些新的氨基酸(aa)突变。重要的是,根据蛋白质结构模型分析,这些突变大多数位于蛋白质分子的表面。我们通过 CRISPR/Cas9 技术构建了一株缺失 gE 和 gI 基因的 SX1911 突变病毒。在小鼠试验中,SX1911-ΔgE/gI 疫苗接种的小鼠得到了与 Bartha-K61 疫苗接种相当的保护。此外,高剂量的灭活 Bartha-K61 保护了小鼠免受致死性 SX1911 攻击,而 Bartha-K61 疫苗接种的小鼠的中和抗体滴度更高、病毒载量更高、组织病理学损伤更严重。这些发现强调了需要持续监测 PRV 并开发新型疫苗或设计新的疫苗接种方案来控制中国的 PRV。